Merck shelves study of cholesterol drug
This is a discussion on Merck shelves study of cholesterol drug within the Biotechnology News forum, part of the Industry News and Updates category; Saying it had the wrong patient population, Merck has discontinued its ACHIEVE imaging study for its cholesterol drug MK-0524A. ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-21-2008, 02:27 PM
|
|||
|
|||
Merck shelves study of cholesterol drug
Saying it had the wrong patient population, Merck has discontinued its ACHIEVE imaging study for its cholesterol drug MK-0524A. Its steering committee recommended a new imaging study that included a Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Cholesterol drug delay signals new FDA standards | industry_news | Biotechnology News | 0 | 04-28-2008 11:21 PM |
| Vioxx Critique Will Not Scuttle Merck Settlement Reuters Health Information, April 17, 2008 | industry_news | Other Clinical Pharmacy News | 0 | 04-17-2008 01:00 PM |
| Study finds big gaps in clinical trial process | industry_news | Biotechnology News | 0 | 04-03-2008 05:16 PM |
© 2008 DrugManagementForum™ powered by |
 |